================================================================================
FORM 8-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 29, 2003
REGENERATION TECHNOLOGIES, INC.
--------------------------------------------------
(Exact name of issuer as specified in its charter)
DELAWARE 0-31271 59-3466543
- ------------------------------- ----------- ------------------
(State or other jurisdiction of (Commission (I.R.S. Employer
Incorporation or Organization) File Number) Identification No.)
11621 RESEARCH CIRCLE
ALACHUA, FLORIDA 32615
----------------------------------------
(Address of Principal Executive Offices)
Registrant's telephone number, including area code (386) 418-8888
None
-----------------------------------------------
(Former address, if changed since last report.)
================================================================================
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(a) Financial Statements.
None
(b) Pro Forma Financial Information.
None
(c) Exhibits
99.1 Regeneration Technologies, Inc. press release dated September
29, 2003.
ITEM 9. REGULATION FD DISCLOSURE.
On September 29, 2003, Regeneration Technologies, Inc. announced revised
revenue guidance for the third quarter ending September 30, 2003. A copy of this
press release is furnished as Exhibit 99.1 to this report on Form 8-K.
(All other items on this report are inapplicable.)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
REGENERATION TECHNOLOGIES, INC.
By /s/ Thomas F. Rose
-------------------------------------
Thomas F. Rose
Vice President and Chief Financial
Officer
Dated: September 29, 2003
EXHIBIT INDEX
99.1 Regeneration Technologies, Inc. press release, dated September 29, 2003.